Pemetrexed-Platinum With or Without Bevacizumab for Chinese Chemo-Naive Advanced Lung Adenocarcinoma Patients: A Real-World Study

• Main Authors: Xin Li (Author), Jie Huang (Author), Yao Qiu (Author), Qianyun Zhang (Author), Shaoyu Yang (Author), Kan Wu (Author), Jiaoli Wang (Author), Limin Wang (Author), Jian Ye (Author), Shenglin Ma (Author), Bing Xia (Author), Xueqin Chen (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Despite recent advances in the treatment of advanced non-small-cell lung cancer (NSCLC), bevacizumab plus platinum-based doublet chemotherapy remains a commonly used first-line regimen. This study was conducted to compare the efficacy and safety of pemetrexed-platinum with or without bevacizumab in...